Narrow search
Showing 1 - 10 of 37
Cover Image
Unmet medical needs in ambulatory care in Hungary : forgone visits and medications from a representative population survey
Lucevic, Armin; Péntek, Márta; Kringos, Dionne; … - In: The European journal of health economics : HEPAC ; … 20 (2019), pp. S71-S78
Persistent link: https://www.econbiz.de/10012060929
Cover Image
Validity and reliability of the 9-item Shared Decision Making Questionnaire (SDM-Q-9) in a national survey in Hungary
Rencz, Fanni; Tamási, Béla; Brodszky, Valentin; … - In: The European journal of health economics : HEPAC ; … 20 (2019), pp. S43-S55
Persistent link: https://www.econbiz.de/10012060924
Cover Image
Patient experiences with outpatient care in Hungary : results of an online population survey
Brito Fernandes, Óscar; Baji, Petra; Kringos, Dionne; … - In: The European journal of health economics : HEPAC ; … 20 (2019), pp. S79-S90
Persistent link: https://www.econbiz.de/10012060932
Cover Image
A certolizumab pegol kezelés rheumatoid arthritisben, irodalmi áttekintés és egészség-gazdaságtani elemzés = Certolizumab pegol in patients with rheumatoid arthritis: systematic re...
Gulácsi, László; Brodszky, Valentin; Péntek, Márta; … - 2009
Persistent link: https://www.econbiz.de/10010124491
Cover Image
Systematic review and analysis of evidences on clinical efficacy and cost-effectiveness of biological drugs for the treatment of Ankylosing Spondylitis
Péntek, Márta - 2013
Technology: Infliximab and comparator biological such as adalimumab, etanercept, golimumab. Conditions: Ankylosing spondylitis (AS) Issue: Infliximab is registered to be used in patients with AS. The aim of the Report is to evaluate the clinical efficacy and safety of infliximab and comparator...
Persistent link: https://www.econbiz.de/10010353085
Cover Image
Systematic review and analysis of evidences on clinical efficacy and cost-effectiveness of biological drugs for the treatment of rheumatoid arthritis
Péntek, Márta; Baji, Petra; Brodszky, Valentin; … - 2014
Persistent link: https://www.econbiz.de/10010434928
Cover Image
Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis.
Baji, Petra; Péntek, Márta; Szántó, Sándor; … - 2014
OBJECTIVES: To compare the efficacy and safety of infliximab-biosimilar with other biological drugs for the treatment of active ankylosing spondylitis (AS). METHODS: Systematic literature review for randomized controlled trials (RCTs) with adalimumab, etanercept, golimumab, infliximab and...
Persistent link: https://www.econbiz.de/10010434939
Cover Image
Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison.
Baji, Petra; Péntek, Márta; Czirjak, László; … - 2014
OBJECTIVE: The aim of this meta-analysis was to compare the efficacy and safety of infliximab-biosimilar and other available biologicals for the treatment of rheumatoid arthritis (RA), namely abatacept, adalimumab, certolizumab pegol, etanercept, golimumab, infliximab, rituximab and tocilizumab....
Persistent link: https://www.econbiz.de/10010434940